A case-control study involving individuals with diabetes highlighted that long-term use of metformin was associated with a slight increase in AD risk, whereas long-term use of sulfonylureas, thiazolidinedione, or insulin was not [112]. The gene discussed is INS; the disease is Alzheimer disease.